Leigh syndrome (Q41128): Difference between revisions

From determinar.ia.br - Determine suas informações
Created a new Item
 
Changed an Item
 
(7 intermediate revisions by the same user not shown)
description / pt-brdescription / pt-br
 
A síndrome de Leigh ou encefalomielopatia necrotizante subaguda é uma doença neurológica progressiva definida por características neuropatológicas específicas que associam lesões no tronco cerebral e nos núcleos da base. Perda de marcos motores, hipotonia com mau controle da cabeça, vômitos recorrentes e anormalidade de movimento são sintomas iniciais comuns. Sinais piramidais e extrapiramidais, nistagmo, distúrbios respiratórios, oftalmoplegia e neuropatia periférica são frequentemente observados posteriormente. A epilepsia é relativamente incomum. A síndrome de Leigh tem múltiplas causas, todas as quais implicam em um defeito na produção de energia aeróbia, variando desde o complexo da piruvato desidrogenase até a via de fosforilação oxidativa.
description / endescription / en
 
Leigh syndrome or subacute necrotizing encephalomyelopathy is a progressive neurological disease defined by specific neuropathological features associating brainstem and basal ganglia lesions. Loss of motor milestones, hypotonia with poor head control, recurrent vomiting, and a movement disorder are common initial symptoms. Pyramidal and extrapyramidal signs, nystagmus, breathing disorders, ophthalmoplegia and peripheral neuropathy are often noted later. Epilepsy is relatively uncommon. Leigh syndrome has multiple causes, all of which imply a defect in aerobic energy production, ranging from the pyruvate dehydrogenase complex to the oxidative phosphorylation pathway.
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/672871576 / rank
 
Normal rank
Property / CURIE
 
CID11:5C53.24
Property / CURIE: CID11:5C53.24 / rank
 
Normal rank
Property / Canary Token
 
dki-india-5C53.24
Property / Canary Token: dki-india-5C53.24 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank
Property / Linked ICD 10
 
Property / Linked ICD 10: G31.8 / rank
 
Normal rank

Latest revision as of 07:12, 13 August 2026

Leigh syndrome or subacute necrotizing encephalomyelopathy is a progressive neurological disease defined by specific neuropathological features associating brainstem and basal ganglia lesions. Loss of motor milestones, hypotonia with poor head control, recurrent vomiting, and a movement disorder are common initial symptoms. Pyramidal and extrapyramidal signs, nystagmus, breathing disorders, ophthalmoplegia and peripheral neuropathy are often noted later. Epilepsy is relatively uncommon. Leigh syndrome has multiple causes, all of which imply a defect in aerobic energy production, ranging from the pyruvate dehydrogenase complex to the oxidative phosphorylation pathway.
Language Label Description Also known as
default for all languages
5C53.24
    English
    Leigh syndrome
    Leigh syndrome or subacute necrotizing encephalomyelopathy is a progressive neurological disease defined by specific neuropathological features associating brainstem and basal ganglia lesions. Loss of motor milestones, hypotonia with poor head control, recurrent vomiting, and a movement disorder are common initial symptoms. Pyramidal and extrapyramidal signs, nystagmus, breathing disorders, ophthalmoplegia and peripheral neuropathy are often noted later. Epilepsy is relatively uncommon. Leigh syndrome has multiple causes, all of which imply a defect in aerobic energy production, ranging from the pyruvate dehydrogenase complex to the oxidative phosphorylation pathway.

      Statements

      CID11:5C53.24
      0 references
      dki-india-5C53.24
      0 references
      Concluído
      0 references
      13 August 2026
      0 references
      0 references